Product Wiki · Recalls · EU Safety Gate (RAPEX)

Ohrringe — recall A12/0356/18

EU Safety Gate (RAPEX) · Germany · 2018-03-09 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/0356/18
Date of alert
2018-03-09
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
Bijou Brigitte
Product category
Jewellery
Product type
Earrings
Reported risk: Die Menge an Nickel, die vom Ohrringverschluss freigesetzt wird, ist zu hoch (Messwert bis zu 2,4 µg/cm²/Woche). Nickel ist ein starkes Sensibilisierungsmittel und kann allergische Reaktionen hervorrufen, wenn es in Artikeln vorhanden ist, die direkt und über längere Zeit mit der Haut in Kontakt kommen. Das Produkt entspricht nicht der REACH-Verordnung.
Action taken by the authority
Type of economic operator taking notified measure
Importer
Category of measure
Withdrawal of the product from the market
Date of entry into force
19/01/2018
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Risk Description (original English): The amount of nickel released by the earring closure is too high (measured value up to 2.4 µg/cm²/week).

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/301971

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.